ARQT Next Earnings Date Notes

— Arcutis Biotherapeutics (ARQT) is a biopharmaceutical company focused on developing & commercializing innovative treatments for dermatological diseases, with a particular emphasis on immune-mediated conditions. Its lead product, ZORYVE (roflumilast cream), is FDA-approved for plaque psoriasis, and the company is progressing clinical programs for additional indications such as atopic dermatitis & seborrheic dermatitis. For investors tracking Arcutis, the key business metrics to monitor include ZORYVE product sales & prescription growth, net product revenue, operating expenses, cash burn rate (& cash runway), as well as pipeline development milestones & regulatory progress for new indications. Pay close attention during the earnings call for updates on formulary access, insurance reimbursement, & market penetration, as these will be critical for driving revenue growth and achieving profitability. Also look for management commentary around competitive landscape, commercial execution, and timelines for clinical trial data readouts. Ultimately, the company's long-term performance will hinge on ZORYVE's market adoption & successful expansion of its dermatology pipeline, making both commercial metrics & R&D progress equally important to assess. The next projected earnings date for ARQT is 8/5/2026 after close (stay tuned for a confirmed earnings date once announced).

ARQT Next Earnings Date FAQ

On this page we presented the ARQT Next Earnings Date information for Arcutis Biotherapeutics along with recent past earnings dates. For Q1 of 2026, ARQT reported earnings of -0.090/share, with the earnings report taking place on 5/6/2026. For Q4 of 2025, ARQT reported earnings of 0.130/share, with the earnings report taking place on 2/25/2026. For Q3 of 2025, ARQT reported earnings of 0.060/share, with the earnings report taking place on 10/28/2025. For Q2 of 2025, ARQT reported earnings of -0.130/share, with the earnings report taking place on 8/6/2025. For Q1 of 2025, ARQT reported earnings of -0.200/share, with the earnings report taking place on 5/6/2025. Based on these past earnings dates, the projected next earnings date for ARQT is 8/5/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Arcutis Biotherapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Arcutis Biotherapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Arcutis Biotherapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next ARQT earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up ARQT's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the ARQT next earnings date.